Tomislav Omrčen

Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix—Final results of a prospective phase II-study

Eduard Vrdoljak, Tomislav Omrčen, Žana Saratlija Novaković et al. · Gynecologic Oncology · 2006 · 31 citations

Medicine, Gynecology, Oncology +9

Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: Results of a phase II study

Eduard Vrdoljak, Tomislav Prskalo, Tomislav Omrčen et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 28 citations

Medicine, Oncology, Chemotherapy +7

Prognostic value of vitamin D receptor and insulin-like growth factor receptor 1 expression in triple-negative breast cancer

Martina Šoljić, Ivana Mrklić, Snježana Tomić et al. · Journal of Clinical Pathology · 2017 · 28 citations

Medicine, Cancer Biology, Oncology +16

Phase II study of bevacizumab in combination with capecitabine as first-line treatment in elderly patients with metastatic colorectal cancer

Eduard Vrdoljak, Tomislav Omrčen, Marijo Boban et al. · Anti-Cancer Drugs · 2010 · 24 citations

Medicine, Oncology, Pharmacotherapy +15

Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU

Khashayar Fakhrian, Arif Deniz Ordu, Florian Lordick et al. · Strahlentherapie und Onkologie · 2014 · 20 citations

Medicine, Oncology, Chemotherapy +8